Metastatic Pancreatic Ductal Adenocarcinoma
Showing 26 - 26 of 26
Metastatic Pancreatic Ductal Adenocarcinoma Trial in Worldwide (MEDI4736 monotherapy, tremelimumab+MEDI4736)
Completed
- Metastatic Pancreatic Ductal Adenocarcinoma
- MEDI4736 monotherapy
- tremelimumab+MEDI4736
-
Tampa, Florida
- +20 more
Jul 9, 2018